Experimental Lilly pill leads to 14.7% weight loss in mid-stage trial
June 23 (Reuters) – In a mid-stage trial, the highest dose of Eli Lilly’s (LLY.N) experimental pill orforglipron led to 14.7% weight loss after 36 weeks for people who were obese or overweight, setting a marker in the race to develop effective oral obesity drugs, researchers said on Friday.Results from a different trial, also presented… […]